Abstract: The present invention discloses a heterocyclic substituted pyrimidopyran compound and use thereof, and specifically discloses a compound represented by formula (VII) and a pharmaceutically acceptable salt thereof.

Abstract: A loading/unloading system for a quay type full-automatic container terminal includes a plurality of shore cranes, an operation lane area between two rails of the shore cranes, an operation area from a rear side of a landside rail of the shore cranes to a yard, an automatic container yard area, an operation lane area of the yard, and facilities behind the yard. The shore cranes are disposed in parallel at a front edge of a container terminal to autonomously complete shipping and unshipping operations of containers, and autonomously complete loading/unloading processes of artificial intelligence transportation robots through information interaction with an artificial intelligence transportation robot system. The operation lane area between two rails of the shore cranes includes: a lambdoidal reverse operation area of inner container trucks, a ship lofting operation area, and a loading/unloading operation area of the inner container trucks, which are physically isolated by fences.

Abstract: Disclosed are a class of compounds having a highly selective inhibition of ROS1, and the use thereof in the preparation of drugs for treating diseases related to abnormal ROS1 kinase expression. Specifically disclosed are compounds represented by formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: The present invention discloses a heterocyclic substituted pyrimidopyran compound and use thereof, and specifically discloses a compound represented by formula (VII) and a pharmaceutically acceptable salt thereof.

Abstract: Disclosed are a pyrrolopyrimidine compound and a use thereof in preparing a medicine for diseases related to a BTK protein kinase inhibitor. Specially, disclosed are a compound as shown in formula (III) and a pharmaceutically acceptable salt thereof.

Abstract: The disclosure provides an intelligent horizontal transportation system for automatic loading or unloading at a container terminal. The system includes a plurality of autonomous transport robots (ATRs) and an ATR control system. The plurality of ATRs are configured to perform horizontal transportation tasks. The ATR control system is in real-time communication with the plurality of ATRs to manage and control the plurality of ATRs; the ATR control system is in real-time communication with a terminal management system, an automated yard crane, and an automated quay crane, so as to coordinate task scheduling between the automated yard cranes, automated quay cranes, and the plurality of ATRs. The ATR control system includes a task scheduling module, a dynamic path planning module, a standardized control interface module, a traffic management module, a lock station management module, a vehicle sequencing module, a charging scheduling module, a parking management module, and a remote driving module.

Abstract: The present invention discloses a bridged ring-substituted heteroaryl-pyran derivative and a use thereof, and in particular discloses a compound as represented in formula (VI) or a pharmaceutically acceptable salt thereof.

Abstract: The present application relates to a pyrimidopyran compound, and specifically discloses a compound as represented by formula (III), and a pharmaceutically acceptable salt thereof.

Abstract: A class of benzoxazinone derivatives and a preparation method therefor, specifically related to a compound shown in formula (II), or a stereoisomer or a pharmaceutically acceptable salt thereof.

Abstract: The present application relates to a pyrimidopyran compound, and specifically discloses a compound as represented by formula (III), and a pharmaceutically acceptable salt thereof.

Abstract: Disclosed are a pyrrolopyrimidine compound and a use thereof in preparing a medicine for diseases related to a BTK protein kinase inhibitor. Specially, disclosed are a compound as shown in formula (III) and a pharmaceutically acceptable salt thereof.

Abstract: A loading/unloading system for a quay type full-automatic container terminal includes a plurality of shore cranes, an operation lane area between two rails of the shore cranes, an operation area from a rear side of a landside rail of the shore cranes to a yard, an automatic container yard area, an operation lane area of the yard, and facilities behind the yard. The shore cranes are disposed in parallel at a front edge of a container terminal to autonomously complete shipping and unshipping operations of containers, and autonomously complete loading/unloading processes of artificial intelligence transportation robots through information interaction with an artificial intelligence transportation robot system. The operation lane area between two rails of the shore cranes includes: a lambdoidal reverse operation area of inner container trucks, a ship lofting operation area, and a loading/unloading operation area of the inner container trucks, which are physically isolated by fences.

Abstract: The disclosure provides an intelligent horizontal transportation system for a completely automatic side-loading/unloading container terminal. The system includes a horizontal transportation device including an unmanned artificial intelligence robot of transportation (ART) and a horizontal transportation control system that intelligently manages and controls the ART to enable it to complete horizontal transportation. The horizontal transportation control system is in real-time connection and communication with a terminal operation system (TOS), an automatic field crane, an automatic shore crane and the ART to complete information interactive processing to realize information interconnection, so as to guarantee real-time utilization of information and intelligent control of the ART. The horizontal transportation control system realizes intelligent management and control of the horizontal transportation device by executing the following functions.

Abstract: Disclosed are a class of compounds having a highly selective inhibition of ROS1, and the use thereof in the preparation of drugs for treating diseases related to abnormal ROS1 kinase expression. Specifically disclosed are compounds represented by formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: Provided is a FGFR inhibitor, designating a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. Also provided is the application of a drug for treating solid tumors, such as FGFR related diseases.

Abstract: Provided is a FGFR inhibitor, designating a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. Also provided is the application of a drug for treating solid tumors, such as FGFR related diseases.

Abstract: Creating a page snapshot is disclosed, including: receiving data associated with a webpage; determining that a page resource associated with the webpage is associated with delayed loading, wherein during a delayed loading process the page resource is configured to be loaded in response to a trigger event; loading the page resource without the trigger event based at least in part on modifying one or more attributes associated with the page resource in the received data associated with the webpage; rendering the loaded page resource; and creating a page snapshot of the webpage including the rendered page resource.